CAS: 96827-04-2 - Cholecystokinin-33(human) (9CI)
Formula:C167H263N51O52S4
- Sinonimi:
- Cholecystokinin-39(pig), 1-de-L-tyrosine-2-de-L-isoleucine-3-de-L-glutamine-4-de-L-glutamine-5-de-L-alanine-6-de-L-arginine-13-L-methionine-15-L-isoleucine-16-L-valine-21-L-asparagine-
- Human cholecystokinin-33
- L-Phenylalaninamide,L-lysyl-L-alanyl-L-prolyl-L-serylglycyl-L-arginyl-L-methionyl-L-seryl-L-isoleucyl-L-valyl-L-lysyl-L-asparaginyl-L-leucyl-L-glutaminyl-L-asparaginyl-L-leucyl-L-a-aspartyl-L-prolyl-L-seryl-L-histidyl-L-arginyl-L-isoleucyl-L-seryl-L-a-aspartyl-L-arginyl-L-a-aspartyl-O-sulfo-L-tyrosyl-L-methionylglycyl-L-tryptophyl-L-methionyl-L-a-aspartyl-
- Cck-33 (Human)
Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
---|---|---|---|---|
Cholecystokinin-33 (human) REF: 01-4036693CAS: 96827-04-2 | 91.0% | 211,00 €~945,00 € | Mar 21 Gen 25 | |
CCK-33 (Human) REF: 3D-PCK-4201-SCAS: 96827-04-2 | Min. 95% | 1.705,00 € | Gio 06 Mar 25 | |
Cholecystokinin-33 (human) trifluoroacetate REF: 3D-FC109504CAS: 96827-04-2 | Min. 95% | 155,00 €~716,00 € | Gio 20 Mar 25 |
Cholecystokinin-33 (human)
CAS:96827-04-2
Formula:
C167H263N51O52S4
Purezza:
91.0%
Colore e forma:
White Lyophilisate
Peso molecolare:
3945.5
Ref: 01-4036693
0.1mg | 211,00 € | ||
0.5mg | 945,00 € |
Consegna stimata in Stati Uniti, il Martedì 21 Gennaio 2025
CCK-33 (Human)
CAS:96827-04-2
CCK-33 is a synthetic peptide that is used as a research tool. It binds to …
Formula:
C167H263N51O52S4
Purezza:
Min. 95%
Peso molecolare:
3,945.4 g/mol
Ref: 3D-PCK-4201-S
100µg | 1.705,00 € |
Consegna stimata in Stati Uniti, il Giovedì 06 Marzo 2025
Cholecystokinin-33 (human) trifluoroacetate
CAS:96827-04-2
Please enquire for more information about Cholecystokinin-33 (human) trifluoroacetate including the price, delivery time and …
Formula:
C167H263N51O52S4
Purezza:
Min. 95%
Peso molecolare:
3,945.45 g/mol
Ref: 3D-FC109504
10µg | 338,00 € | ||
25µg | 338,00 € | ||
50µg | 470,00 € | ||
100µg | 716,00 € |
Consegna stimata in Stati Uniti, il Giovedì 20 Marzo 2025